CCEL vs TFC · P/E 490, $39.6M cap vs rev $24.54B
CryoCell International Inc (CCEL) versus TFC (TFC) — a side-by-side from cached financials, not a winner call.
CryoCell International Inc (CCEL) is a medical care facilities company listed on US.
TFC (TFC) common stock.
CCEL does not have a complete income-statement cache yet.
Latest reported TFC revenue for 2025-12-31 was $24.54B. Net income was $5.31B. Revenue was down 2.1% from 2024-12-31 to 2025-12-31. TFC currently screens at market cap $0.
CCEL currently screens at market cap $39.6M and trailing P/E 490.0. TFC currently screens at market cap $0.
Not investment advice. Open the CCEL and TFC stock pages for the full models.
Not investment advice.